Evidence map›Paper›PMID 40531975›Full record

ArticlePloS one2025

Tracheostomy in COVID-19: A retrospective cohort study of outcomes and mortality predictors in a specialized infectious disease hospital in Brazil.

André Figueiredo Accetta, Denise Machado Medeiros, Maria Pia Diniz Ribeiro, Sandra Wagner Cardoso, Isabel Cristina Ferreira Tavares, Valdilea Gonçalves Veloso, Hugo Boechat Andrade, André Miguel Japiassú

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

André Figueiredo AccettaSchool of Medicine, Universidade Federal Fluminense (UFF), Niterói, Rio de Janeiro, Brazil.ORCID 0009-0006-8555-5233
Denise Machado MedeirosInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.
Maria Pia Diniz RibeiroInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.
Sandra Wagner CardosoInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.
Isabel Cristina Ferreira TavaresInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.
Valdilea Gonçalves VelosoInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.
Hugo Boechat AndradeInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0001-6781-6125
André Miguel JapiassúInstituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-9444-9890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic profoundly impacted critical care practices, leading to a significantly increase in tracheostomies for patients with respiratory failure. This study aimed to investigate prognostic factors associated with mortality in COVID-19 patients undergoing tracheostomy for respiratory failure in the intensive care unit of a specialized infectious disease hospital in Brazil. RESEARCH QUESTION: What is the impact of the timing of tracheostomy on the outcome of COVID-19 patients?. MATERIALS AND

methodsThis retrospective cohort study analyzed 356 COVID-19 patients who underwent tracheostomy at the Evandro Chagas National Institute of Infectious Diseases (INI) in Brazil between May 2020 and December 2023. Data on demographics, comorbidities, illness severity, surgical factors, and outcomes were extracted from medical records. Multivariate logistic regression was performed to identify factors associated with hospital mortality.

resultsThe overall hospital mortality rate was 68%. Independent factors associated with mortality included age over 60 years, chronic pulmonary disease, diabetes, lack of COVID-19 vaccination, hemodialysis on the day of surgery, and a PaO2/FiO2 ratio lower than 200 on the day of surgery. The timing of tracheostomy (after 21 days of mechanical ventilation) was not associated with mortality.

conclusionsThis study offers valuable insights into the complex factors influencing mortality in critically ill COVID-19 patients. Our findings underscore the importance of assessing both patient characteristics and illness at the time of tracheostomy to predict outcomes which is more critical than basing the decision solely on the duration of endotracheal intubation or mechanical ventilation.

Indexed as

COVID-19TracheostomyAdultAgedBrazilFemaleHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedPrognosisRespiration, ArtificialRetrospective StudiesRisk FactorsSARS-CoV-2

Identifiers

PMID40531975
PMCPMC12176168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.